ABBV
AbbVie Inc.
- EBITDA, 2025
- $23.2B
- YoY, 2025
- +32.5%
- 5-year CAGR
- +5.4%
- 10-year CAGR
- +10.7%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $23.2B | +32.5% |
| 2024 | $17.5B | −18.3% |
| 2023 | $21.5B | −19.3% |
| 2022 | $26.6B | +0.5% |
| 2021 | $26.4B | +48.3% |
| 2020 | $17.8B | +18.9% |
| 2019 | $15.0B | +84.1% |
| 2018 | $8.1B | −26.2% |
| 2017 | $11.0B | +4.9% |
| 2016 | $10.5B | +25.7% |
| 2015 | $8.4B | +99.5% |
| 2014 | $4.2B | −36.0% |
| 2013 | $6.6B | −5.8% |
| 2012 | $7.0B | +42.4% |
| 2011 | $4.9B | — |